Take a look at some of Thursday's midday movers:
American International Group - The insurer fell after CEO Robert Benmosche said in an interview with Bloomberg News that he is departing the company this weekend after learning he has at most a year to live.
Amgen - The drug maker rose after saying it had applied to U.S. regulators to sell its cholesterol drug.
Cliffs Natural Resources - The miner and rivals including Rio Tinto, Vale and BHP Billiton dropped along with with iron-ore prices.
CSR - The U.K.-based maker of Bluetooth devices surged after it rejected an approach by U.S. rival Microchip Technology.
Genesco - The footwear maker fell after posting weaker-than-expected second-quarter earnings and cutting its full-year outlook.
GT Advanced Technologies - The solar and LED-equipment maker fell after Raymond James cut its rating to underperform from market perform.
Johnson & Johnson - The pharmaceutical company edged lower as it recalled some lots of implants used to correct defects of the jaw after more than a dozen cases of injury.
Lannett - The distributor of generic drugs gained after reporting a large rise in quarterly sales.
Lear - The maker of auto seats and electrical-power systems gained after saying it would acquire automotive-leather supplier Eagle Ottawa for $850 million.
Lululemon Athletica - The maker of yoga clothes fell after D.A. Davidson cut the stock to neutral from buy.
OncoMed Pharmaceuticals - The biotechnology company gained after U.S. regulators lifted a partial hold on its cancer-drug trials.
Signet Jewelers - The retailer rose after reporting second-quarter revenue that beat estimates.
Tekmira Pharmaceuticals - The Canadian drug company gained after Daily Mail reported the developer of an Ebola drug was a likely takeover target.
()
—By CNBC's Rich Fisherman.
Questions? Comments? Email us at marketinsider@cnbc.com